Recon: FDA lifts hold on BioNTech’s cancer drug trial; Humana settles Medicare drug overcharging suit for $90M
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsUnited StatesReconJason ScottBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsUnited States